Added to YB: 2025-09-09
Pitch date: 2025-09-06
COLO-B.CO [neutral]
Coloplast A/S
-7.28%
current return
Author Info
Kontra Investment Xchange is trying to build wealth by investing in good companies and letting those investments compound over many years. Sign up for the newsletter.
Company Info
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally.
Market Cap
DKK 141.5B
Pitch Price
DKK 608.30
Price Target
N/A
Dividend
3.50%
EV/EBITDA
18.74
P/E
34.78
EV/Sales
5.92
Sector
Health Care Equipment and Supplies
Category
growth
Coloplast’s ($COLO-B) Capital Markets Day 2025
COLO-B.CO (update): Danish medtech leader targets 7-8% organic revenue CAGR through 2030 vs 4-5% market growth, EBIT growth at/above revenue, 20%+ ROIC by 2030. Trades 26.5x FY25 P/E, 17x EV/EBITDA. Risks include China slowdown, healthcare reforms, execution on Atos/Kerecis integrations.
Read full article (6 min)